Schedule 13G ownership disclosure

REVANCE THERAPEUTICS INC

Common Stock, par value $0.001 per share · CUSIP: 761330109

Event date: 2025-02-28

Filing-level shares
0.0
Percent of class
0.0%
  • JPMORGAN CHASE & CO.

    Shares: 0.0 · Class: 0.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000019617-25-000296
Form type
SCHEDULE 13G/A
Filer
JPMORGAN CHASE & CO
CIK
CIK 19617
Filed
Mar 06, 2025
Reporting period
Feb 28, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub